NewSquare Capital’s CareDx CDNA Stock Holding History

NewSquare Capital’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10	Closed	-$85	–	645
2023 Q2	$85	Hold	10	–	–	﹤0.01%	800
2023 Q1	$91	Hold	10	–	–	﹤0.01%	830
2022 Q4	$114	Buy	+10	New	+$148	﹤0.01%	766

Other funds holding CDNA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

NewSquare Capital's CDNA Position: Q3 2023 in Review

NewSquare Capital sold out of CareDx (CDNA) in Q3 2023, closing a stake of 10 shares — an estimated $85 sold.

NewSquare Capital first reported a position in CDNA in Q4 2022 and held it in 3 quarters. The position peaked at $114 in Q4 2022. 150 funds tracked by Wall St. Rank hold CDNA as of Q3 2023.

NewSquare Capital reported no remaining CareDx position as of Q3 2023 after selling out during the quarter.
NewSquare Capital sold 10 CareDx shares in Q3 2023, an estimated $85.
NewSquare Capital first reported a position in CareDx in Q4 2022 and held it in 3 quarters.
NewSquare Capital's CareDx position peaked at $114 in Q4 2022.
150 funds tracked by Wall St. Rank held CareDx as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.